Patent · US Active

Composition comprising a mixture of CD95-Fc isoforms

US9657083B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

APOGENIX AG · DE

Inventors

Oliver Hill · Neckarsteinach, DE
Christian Gieffers · Dossenheim, DE
Meinolf Thiemann · Schriesheim, DE

Key dates

Filing date	Apr 18, 2016
Grant date	May 23, 2017
Priority date	—
Expiry date	Apr 18, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising a mixture of fusion protein isoforms, each fusion protein comprising an extracellular CD95 domain or a functional fragment thereof or an Fc domain or functional fragment thereof, formulations providing such composition in a stable form as well as a method for producing such a composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.